The Company is excited to announce that its first invested and consulted ICO, NUVUS.IO, is set to go live on February 8, 2018
Nuvus is aiming to raise $35M to $100M in a token exchange, depending on market conditions.
Nuvus has been developing their strategy to consolidate the medical Cannabis industry since 2014 and began planning its ICO in mid-2016.
The ICO will run for 76 days and may conclude early if softcap reached.
Nuvus has ensembled power players in the industry including one of the largest growers in AZ, well regarded industry players and thought leaders.
Nuvus is expected to bring on board members as they progress.
Nuvus Ecosystem called Nuvus Protocol which will be based on public and permission based private Blockchain technology using IBMs Hyperledger and Hyperledger.org
Nuvus will be utilizing its CognetiX software as data acquisition & management software as nodes which together with Oracles will unify amorphous data from all sources and package them for inclusion into the Nuvus blockchain ecosystems via the Nuvus Protocol.
Nuvus Protocol will ensure compliance standards are adhered to at each level of the cycle.
Patients, doctors, researchers and regulators want to ensure that the product that is bought and the claims made by the producers are genuine.
IFXY invests in crypto assets, provides blockchain technology consulting, ICO process consulting services and tokenization of assets.
Adoption of Agreement and Plan of Merger and Consummation of Holding Company Reorganization
On November 7, 2017, Infrax implemented a holding company reorganization pursuant to the Agreement and Plan of Merger (the “Merger Agreement”), dated as of November 1, 2017, among Infrax, Crypto and NUV SUB Inc., a Nevada corporation (“Merger Sub”), which resulted in Crypto owning all of the outstanding capital stock of Infrax.
Pursuant to the CryptoMerger, Merger Sub, a direct, wholly owned subsidiary of Crypto and an indirect, wholly owned subsidiary of Infrax, merged with and intoInfrax, with Infrax surviving as a direct, wholly owned subsidiary of Crypto.
Each share of each class of Infrax stock issued and outstanding immediately prior to the Crypto Merger automatically converted into an equivalent corresponding share of Crypto stock, having the same designations, rights, powers and preferences and the qualifications, limitations and restrictions as the corresponding share of Infrax stock being converted.
Accordingly, upon consummation of the CryptoMerger, Infrax’s stockholders immediately prior to the consummation of the CryptoMerger became stockholders of Crypto.
The stockholders of Infrax will not recognize gain or loss for U.S. federal income tax purposes upon the conversion of their shares in the CryptoMerger.
News 
Market Data 
Discover 
AI
